The EPS projection of Marathon Patent Group, Inc. (NASDAQ:MARA) for quarter ended 2016-09-30 is $-0.21. A week before, the EPS forecast was $-0.21 against target of $-0.21, a month earlier. This estimate stood at $-0.21 60 days earlier versus forecast of $-0.21 90 days earlier, confirming a deviation of 0%.
Marathon Patent Group, Inc. (NASDAQ:MARA) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Marathon Patent Group, Inc. (NASDAQ:MARA) in the preceding 120, 60, 30 and 90 days were 1, 2, 0 and 2, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Marathon Patent Group, Inc. (NASDAQ:MARA) was $-0.21. This projection was computed after accounting 2 calls. As reported on 2016-05-12 the EPS was $-0.18. The change was $0.06, demonstrating a percentage deviation of 25%. The projections confirmed a standard deviation of 0.16.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Marathon Patent Group, Inc. (NASDAQ:MARA) stands at $2.92 and the median estimate at $2.92. Almost 2 analysts announced their estimates.
The highest estimate is $3 while the lowest target is $2.84 showing standard deviation of 0.113%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Marathon Patent Group, Inc. (NASDAQ:MARA) stated that the change in forecast was -81.588%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...